The Stop TB Partnership and partners call on high TB burden countries to invest in interventions that overcome the prevalent human rights barriers, currently diminishing the effectiveness of national TB control efforts.

TB Vax ARM launches a campaign calling on the European leadership to fulfil their political and funding commitment to deliver new vaccines to end TB by 2030.

Advocates urge the Indian government to stop using kanamycin for the treatment of drug-resistant TB and instead scale up access to all oral regimens.

The Stop TB Partnership launches the Challenge Facility for Civil Society Round 11 with USD 9 million in funding for civil society and communities from high TB burden countries.

The Stop TB Partnership, aiming to increase attention about TB with the general population, launches awareness efforts at the heart of New York City at Times Square.

Can patents affect access to TB preventive treatment? - a community guidebook, produced by the ARK Foundation of Nagaland, India

Statement on 2021 G-FINDER Report

A report released by the Global Coalition of TB Activists (GCTA).

Invest to End TB. Save Lives.
World leaders have only limited time until December 2022 to keep the promises made to their citizens and nations at the 2018 UN High-Level Meeting on TB.

New TB funding trends report finds that funding for TB research in 2020 reached only US$915 million – less than half of investment needed to end TB.